Dimensional Fund Advisors LP X4 Pharmaceuticals, Inc Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$0.82 - $2.49 $3,290 - $9,992	-4,013 Reduced 6.77%	55,296 $107,000
Q3 2022 Nov 10, 2022	SELL	$0.89 - $1.71 $1,869 - $3,591	-2,100 Reduced 3.42%	59,309 $101,000
Q1 2022 May 13, 2022	SELL	$1.48 - $2.58 $7,046 - $12,283	-4,761 Reduced 7.2%	61,409 $107,000
Q4 2021 Feb 09, 2022	SELL	$1.9 - $5.6 $13,917 - $41,020	-7,325 Reduced 9.97%	66,170 $152,000
Q3 2021 Nov 12, 2021	SELL	$4.53 - $6.45 $234,663 - $334,122	-51,802 Reduced 41.34%	73,495 $389,000
Q2 2021 Aug 12, 2021	BUY	$6.49 - $9.56 $506,135 - $745,555	77,987 Added 164.84%	125,297 $814,000
Q1 2021 May 14, 2021	BUY	$6.63 - $10.28 $313,665 - $486,346	47,310 New	47,310 $407,000

105

100M

213K

50.6K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $23.3M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.